By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mundipharma AG 

St. Alban-Rheinweg 74

Basel    CH-4006  Switzerland
Phone: 41-61-2051112 Fax: 41-61-2051109



Company News
Mundipharma AG Presents Four Posters On “Pain Management In Asia” At The International Association For The Study Of Pain’s 15th World Congress On Pain In Buenos Aires, Argentina 10/6/2014 10:38:43 AM
Skyepharma PLC (SKYEF)’s Partner Mundipharma AG Announces Results Of Pivotal Phase III Study For Flutiform® In Paediatric Asthma 9/8/2014 9:11:21 AM
SkyePharma Inc. (SKYE) Release: Flutiform® Launched In France €3 Million Milestone Receivable From Mundipharma AG 2/10/2014 9:34:03 AM
Mundipharma AG Research Becomes The Latest Pharmaceutical Company To Choose BioClinica, Inc.'s Industry-Leading Clinical Trial Management System 1/28/2014 11:04:16 AM
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013 7:15:07 AM
SkyePharma Inc. (SKYE) Release: flutiform® Launch in Italy Triggers €2 Million Milestone From Marketing Partner Mundipharma AG 6/20/2013 8:49:52 AM
Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million 5/11/2011 6:52:33 AM
Skyepharma PLC (SKYE) - Re Agreement 3/31/2009 12:46:13 PM
Skyepharma PLC (SKYE) Research Update 1/21/2009 10:18:47 AM
Sosei Group Corporation Announces Buyback of the Commercialization Rights to AD 923 from Mundipharma AG 12/29/2008 6:59:33 AM